All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Pharmaco-refractory chronic heart failure - the need for drug level tailored management

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10126865" target="_blank" >RIV/00179906:_____/12:10126865 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11150/12:10126865

  • Result on the web

    <a href="http://www.sciencedirect.com/science/article/pii/S0306987712003271" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0306987712003271</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.mehy.2012.07.017" target="_blank" >10.1016/j.mehy.2012.07.017</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Pharmaco-refractory chronic heart failure - the need for drug level tailored management

  • Original language description

    Pharmacorefractory chronic heart failure is a serious world-wide problem of systolic dysfunction not improving despite evidence based chronic heart failure pharmacotherapy. With the aim to reverse the poor pharmacorefractory chronic heart failure prognosis, severe sophisticated technical therapeutic approaches (from cardiac resynchronization usually with implantable cardioverter-defibrillator to heart transplantation) have been clinically adopted and detached at least for the most eligible pharmacorefractory chronic heart failure patients. However, both significant limitations of these highly specialised therapeutic techniques (cost, uncertain individual effect, complication, adverse effect, waiting list) and the pharmacorefractory chronic heart failure hopelessness for unfit patients make the effort to stop the pharmacorefractory chronic heart failure genesis never ending longing. Regarding growing knowledge on differences in pharmacokinetics, authors assume that the relative undertre

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Medical Hypotheses

  • ISSN

    0306-9877

  • e-ISSN

  • Volume of the periodical

    79

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    4

  • Pages from-to

    560-563

  • UT code for WoS article

    000310765300002

  • EID of the result in the Scopus database